The Multiple Myeloma Research Foundation Shared Music and Hope with 800 Guests While Raising Funds for Cancer Research

Nineteen-Time Grammy Award-Winning Performer Tony Bennett, along with Tony Award-Winning star of theater, film and television James Naughton, joined the Multiple Myeloma Research Foundation (MMRF) at its Annual Fall Gala October 28, 2017 in  Greenwich.

Republic Records Founders and Chief Officers Avery and Monte Lipman were honored with the MMRF Spirit of Hope Award, and Principal Trumpeter of the Dallas Symphony Orchestra, Ryan Anthony, served as the evening’s Patient Speaker and was honored with the MMRF Courage and Commitment Award.

Both of these awards are presented to people in recognition of their extraordinary contributions and inspiration of hope through their life’s work and their dedication to the MMRF and its mission.

Takeda Oncology was the evening’s longtime presenting sponsor.

“The Fall Gala has always been a tremendous evening of celebration and gratitude for the remarkable progress we have made in cancer research,” said MMRF President and Chief Executive Officer Paul Giusti.

The MMRF Fall Gala was attended by 800 supporters including patients, family members, healthcare leaders and business executives who all share a mission to find a cure.

The Multiple Myeloma Research Foundation is one of the leading cancer research organizations in the world. MMRF’s groundbreaking precision medicine model is the only end-to-end solution in cancer research today and the foundation is leading the way in the fight against all cancers with a goal of finding a cure.

About Multiple Myeloma
Multiple myeloma is a cancer of the plasma cell. It is the second most common blood cancer. An estimated 30,000 adults will be diagnosed this year and 12,500 people are predicted to die from the disease.

About the Multiple Myeloma Research Foundation (MMRF)
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentless pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501 (c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $350 million and directs nearly 90% of the total funds to research and related programs. As a result, the MMRF has been awarded by Charity Navigator’s coveted four-star rating for 12 years, the highest designation for outstanding fiscal responsibility and exceptional efficiency.